SCHEMBL4935491

SCHEMBL4935491

CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(Cl)ncn4)cc3)cc2Cl)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.65
TNNI3K Q59H18 5/20 0.65
MKNK2 Q9HBH9 4/20 0.65
MAPK14 Q16539 4/20 0.65
MKNK1 Q9BUB5 3/20 0.65
SRC P12931 3/20 0.65
RET P07949 3/20 0.65
ABL1 P00519 3/20 0.65
BRAF P15056 3/20 0.65
CDK2 P24941 2/20 0.65
CDK8 P49336 2/20 0.65
AXL P30530 2/20 0.65
FLT3 P36888 2/20 0.65
MERTK Q12866 2/20 0.65
HCK P08631 2/20 0.65
BCR P11274 2/20 0.65
STK25 O00506 1/20 0.65
CIT O14578 1/20 0.65
MAP2K7 O14733 1/20 0.65
IKBKB O14920 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4938606 0.93 HCK (0.63) KDRTNNI3KMKNK2MAPK14MKNK1
SCHEMBL4931588 0.90 KDR (0.59) KDRTNNI3KMKNK2MAPK14MKNK1
SCHEMBL3183607 0.89 SRC (0.82) KDRTNNI3KMKNK2MAPK14MKNK1
SCHEMBL3166612 0.84 KDR (0.53) KDRTNNI3KMKNK2MAPK14MKNK1
SCHEMBL4937815 0.83 SRC (0.69) KDRTNNI3KMKNK2MAPK14MKNK1
SCHEMBL3182200 0.83 KDR (0.52) KDRTNNI3KMKNK2MAPK14MKNK1
SCHEMBL4937797 0.82 SRC (0.72) KDRTNNI3KMKNK2MAPK14MKNK1
SCHEMBL3182860 0.82 CHRM1 (0.52) KDRTNNI3KMKNK2MAPK14MKNK1
SCHEMBL3173197 0.82 KDR (0.59) KDRTNNI3KMKNK2MAPK14MKNK1
SCHEMBL22592381 0.81 KDR (0.68) KDRTNNI3KMKNK2MAPK14MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US claimed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases RET, PRKDC, PRKACA KDR 1309/4885TNNI3K 314/4885MKNK2 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.